ETH News

During her doctoral studies, Liliane Ableitner developed a trading and billing tool for energy communities. Three years on, she is CEO of a flourishing start-up with 20 employees.

It doesn’t have to be a hurricane or a tsunami — even a simple running water tap induces a shock wave upon impact with the sink. Now, with the help of the Swiss National Supercomputing Centre's (CSCS) supercomputer “Piz Daint”, mathematician Siddhartha Mishra of ETH Zurich is working to overcome current barriers to simulating and comprehending highly turbulent flows.

Peter Schmidt has been working in development aid for over 30 years, constantly seeking ways to help people help themselves. His first visit to India left him in shock for three days – but ended up shaping the rest of his life.

When working with neural networks, their training is the single most resource-demanding and costly process. Scientists at the ETH Zurich have now developed a software that considerably speeds up training. This will be especially relevant for scientific applications of future users of “Alps” at CSCS.

These days, the cause of death in cancer patients often isn’t the primary tumour, but metastases. With his research, biochemist Nicola Aceto has found a new way to prevent the formation of such secondary tumours. To achieve this, the Latsis laureate had to repeatedly fight against the prevailing wisdom.

Intense agricultural use is causing soil degradation in many areas. Now researchers at ETH Zurich have developed a rapid test for measuring soil quality on site. This should allow farmers to monitor the health of their land themselves in the future.

Chiara Gattinoni, a materials theorist and Marie Curie Fellow at ETH Zurich, uses the “Piz Daint” supercomputer at CSCS to investigate a special class of materials: ferroelectrics. In the future, these materials could constitute the heart of low-energy-consuming, miniaturised data storage in electrical devices. One ferroelectric Gattinoni analysed is, according to her, truly magical.

Many cells in the body must pass through tissue, which sometimes requires them to get out of tight corners. An international research team co-led by ETH Zurich has now examined how cells recognise and escape from such bottlenecks. Among the results of the team’s work are new pointers for how to improve immunotherapy.

Whether for explosives, plastic, dyes or medications: some molecules are manufactured in large quantities on an industrial scale. Yet these production processes are resource-intensive and produce hazardous waste. ETH chemist Dmitry Katayev is making these processes more efficient and better for the environment.

Some people are better protected than others against urinary tract infections. This may be because their bodies produce more of a protein called uromodulin. An interdisciplinary research team has now found out how this helper protein brings relief when nature calls and how this knowledge might benefit the treatment and prevention of these painful inflammations.

Trading in digital currencies such as Bitcoin or Ether has become an established practice but using them as a payment means is still a slow process. ETH Professor Srdjan Capkun and his team have now developed a system that makes cryptocurrency payments secure, fast and practical.

They should be fast, portable and easy to use: blood tests that can be done at home. Having already come up with a prototype, ETH Pioneer Fellow Alexander Tanno is working with doctoral student Yves Blickenstorfer to bring the idea to market.

Mariëlle van Kooten’s ingenious idea won the ETH doctoral student second place in the international Falling Walls Lab in Berlin. She is developing an app that creates simple images from complex medical data. This makes it easier for the untrained eye to navigate the data jungle.

This year Renana Gershoni-Poranne was awarded a Branco Weiss Fellowship. The ETH chemist will use the research grant to design innovative compounds that can be used in future generations of electronic devices.

It has recently become clear just how important membraneless organelles are for cells. Now biochemists at ETH Zurich have discovered a novel mechanism that regulates the formation of these organelles. This has laid the foundation for more targeted research into diseases such as Alzheimer’s or ALS.

Very little was known till now about DNA repair by homologous recombination, which is fundamental for human health. Now an ETH research group has for the first time isolated and studied all the key proteins involved in this process, laying the foundation for investigating many diseases.

A new method developed by biophysicists at ETH Zurich has made it possible for the first time to detect and analyse signals between individual cells.